I think this happens all over, and there are different explanations such as "experimental", that are used...when there is no generic to use as an alternative solution....well...does it come back to just saving dollars again? BD
Some HMOs in New York state are restricting patients' access to so-called single-source drugs, brand-name medications for specific ailments that do not have lower-cost generic versions, according to a report released on Sunday, the New York Daily News reports. The report, released by state Sen. Jeffrey Klein (D), involved a survey of the 15 HMOs with drug plans in the state -- including Aetna, Oxford Health Plans, Cigna, Health Insurance Plan of New York, Group Health Associates and HealthNet of New York. Klein surveyed the HMOs to determine how and whether the companies restrict prescriptions to 20 common single-source drugs.
0 comments :
Post a Comment